Issa F Khouri
M.D. Anderson Cancer Center · UT MD Anderson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Issa F Khouri as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 21:14 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT04022239 · Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell TransplantM.D. Anderson Cancer Center · recruiting · Hematopoietic and Lymphoid System Neoplasm · principal investigator
- Ph2NCT03856216 · Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell TransplantationM.D. Anderson Cancer Center · terminated · Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Lymphocytic Neoplasm · principal investigator
- Ph2NCT02272686 · Ibrutinib Post Stem Cell Transplantation (SCT) in Double-Hit B-Cell LymphomaM.D. Anderson Cancer Center · terminated · Lymphoma · principal investigator
- Ph1NCT01926665 · Carfilzomib Consolidation Therapy After Autologous Stem Cell Transplantation (ASCT) for Mantle Cell Lymphoma (MCL), T-cell Lymphoma (TCL), and Diffuse Large B-Cell Lymphoma (DLBCL)M.D. Anderson Cancer Center · completed · Lymphoma · principal investigator
- Ph1/Ph2NCT01538472 · Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for LymphomaM.D. Anderson Cancer Center · completed · Lymphoma · principal investigator
- Ph2NCT01490723 · Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)M.D. Anderson Cancer Center · completed · Leukemia, Lymphoma · principal investigator
- Ph2NCT01329900 · Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's LymphomasM.D. Anderson Cancer Center · completed · Lymphoma · principal investigator
- Ph2NCT00899431 · Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)M.D. Anderson Cancer Center · terminated · Chronic Lymphocytic Leukemia · study chair
- Ph2NCT00591630 · Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell TransplantationM.D. Anderson Cancer Center · completed · Diffuse Large Cell Lymphoma, Lymphoma · principal investigator
- Ph2NCT00536978 · Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid MalignanciesM.D. Anderson Cancer Center · completed · Lymphoma, Leukemia · principal investigator
- N/ANCT00525876 · Non-Myeloablative Allogeneic Stem Cell TransplantationM.D. Anderson Cancer Center · completed · Lymphoma · principal investigator
- Ph2NCT00505921 · Autologous and Allogenic Transplantation With Campath-1H for T-Cell LymphomaM.D. Anderson Cancer Center · terminated · Lymphoma · principal investigator
- Ph1NCT00383994 · Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell TransplantationM.D. Anderson Cancer Center · completed · Lymphoma, Leukemia, Transplantation, Stem Cell · principal investigator
- Ph1/Ph2NCT00048737 · Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid MalignanciesM.D. Anderson Cancer Center · completed · Lymphoma, Leukemia · principal investigator
- N/ANCT00038844 · Safety and Efficacy of Campath in Nonmyeloablative TransplantationM.D. Anderson Cancer Center · completed · Lymphoma, Leukemia · principal investigator
- N/ANCT00038883 · Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid MalignanciesM.D. Anderson Cancer Center · terminated · Leukemia, Lymphocytic, Chronic, Leukemia, Lymphocytic, Acute, Lymphoma, Low-Grade · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 21:14 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 21:14 UTC. The ranking covers the 200 most relevant of 35 PubMed records, and a shared surname and initials can bring in a namesake. All 35 on PubMed
- 278 citationsRCR 6.2
- 241 citationsRCR 5.6
- Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors.Biol Blood Marrow Transplant · 2014183 citationsRCR 6.1
- Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results.J Clin Oncol · 1994180 citationsRCR 5.8
- Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease.Br J Haematol · 2005138 citationsRCR 3.5
- 118 citationsRCR 2.5
- 109 citationsRCR 2.2
- Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy.Ann Oncol · 1999105 citationsRCR 2.4
- Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas.J Clin Oncol · 2005105 citationsRCR 2.2
- 87 citationsRCR 2.0